HUMAN CLINICAL TRIAL EVALUATING SAFETY
AND EFFICACY OF ARTHRI-ZEN RELIEF

"Seventy five subjects with extreme arthritis pain were recruited for the study. To qualify, subjects had to have daily pain at level 9 to 10 on a scale of 1-10. Fifty of the participants took Arthri-Zen Relief®; 25 took placebo.

...Subjects taking placebo had no change in pain level during the study. By day 4, however, only 53.1 percent of those taking the Arthri-Zen Relief® were still at pain level 9-10. Three days later, that figure dropped to 6.1 percent, and by day 7, it was 0 percent. On the tenth day, a full 85.7 percent of patients were reporting no pain at all. And by day 14, every single one of the people in the test group was completely pain-free. No rescue medications were allowed over the course of the 30-day trial – which means the effects were solely due to the Arthri-Zen Relief®. "

• Download Arthri-Zen Clinical Study
• Read Clinical Study online
• Download Press Release PDF file
• Yahoo Financial News

MIGRA-ZEN RELIEF PLUS "FOUND TO BE HIGHLY EFFECTIVE"

"MIGRA-ZEN RELIEF PLUS was shown to be a highly effective product for the
complete elimination or substantial reduction in the frequency of migraine
headache attacks.

.Furthermore, MIGRA-ZEN RELIEF PLUS was also shown to completely eliminate or substantially reduce the pain associated with migraine headaches.

Neither the product nor its ingredients have any known adverse side effects or interactions with any drug or food. The timecourse and strength of its effects
make it a viable alternative to pharmaceutical approaches to migraine control."

• Download Migra-Zen Clinical Study
• Download Press Release PDF file
• Read Migra Zen Study Online

CLINICALLY TESTED AT THE PALM BEACH RESEARCH CENTER IN WEST PALM BEACH, FLORIDA

"By the end of the 30-day treatment, 67.6 % of the study subjects showed up to 80% reduction of pain, 75% of the study subjects reported up to 75% improvement in daily living, and 58.3 % of the subjects reported as much as 83% reduction in stiffness. Sixteen point seven percent (16.7%) of the study subjects reported little or no pain relief, 16.7% of the study subjects reported little or no improvement in quality of living, and 33.3% of the study subjects reported little or no reduction in stiffness. No adverse event or experience was reported by the study subjects, indicating that ARTHRI-ZEN RELIEF is safe and well tolerated. In conclusion, ARTHRI-ZEN RELIEF showed a positive effect on overall pain, overall daily living and overall level of stiffness in patients with mild to moderate arthritis."

• Download Research Summary